Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway
Abstract Neuropathic pain poses a significant clinical challenge, largely due to the incomplete understanding of its molecular mechanisms, particularly the role of mitochondrial dysfunction. Bioinformatics analysis revealed that pyroptosis and inflammatory responses induced by spared nerve injury (S...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | The Journal of Headache and Pain |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10194-025-01953-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571439252766720 |
|---|---|
| author | Baolong Li Kaiming Yu Xiongyao Zhou Jialu Sun Le Qi Weiye Li Tuo Yang Weizhen Li Ningning Wang Xiaosong Gu Shusen Cui Rangjuan Cao |
| author_facet | Baolong Li Kaiming Yu Xiongyao Zhou Jialu Sun Le Qi Weiye Li Tuo Yang Weizhen Li Ningning Wang Xiaosong Gu Shusen Cui Rangjuan Cao |
| author_sort | Baolong Li |
| collection | DOAJ |
| description | Abstract Neuropathic pain poses a significant clinical challenge, largely due to the incomplete understanding of its molecular mechanisms, particularly the role of mitochondrial dysfunction. Bioinformatics analysis revealed that pyroptosis and inflammatory responses induced by spared nerve injury (SNI) in the spinal dorsal horn play a critical role in the initiation and persistence of neuropathic pain. Among the factors involved, TSPO (translocator protein) emerged as a key regulator. Our experimental findings showed that TSPO expression was upregulated during neuropathic pain, accompanied by mitochondrial dysfunction, specifically manifested as impaired mitochondrial biogenesis, disrupted mitochondrial dynamics (including insufficient expression of mitochondrial biogenesis and fusion-related proteins, as well as significantly increased expression of fission-related proteins), and activation of pyroptosis. Pharmacological upregulation of TSPO, but not its downregulation, effectively alleviated SNI-induced pain hypersensitivity, improving mitochondrial function and reducing pyroptosis. Immunofluorescence staining confirmed that TSPO was primarily localized in astrocytes, and its expression mirrored the protective effects on mitochondrial health and pyroptosis prevention. PCR array analysis suggested a strong association between TSPO and the mitochondrial regulation pathway AMPK-PGC-1α. Notably, inhibition of AMPK-PGC-1α abolished TSPO effects on mitochondrial balance and pyroptosis suppression. Furthermore, Mendelian randomization analysis of GWAS data indicated that increased TSPO expression was linked to pain relief. Through drug screening, molecular docking, and behavioral assays, we identified zopiclone as a promising TSPO-targeting drug for pain treatment. In summary, this study enhances our understanding of the molecular interplay between TSPO, mitochondrial health, and neuropathic pain, highlighting TSPO as a potential therapeutic target for pain management. Graphical Abstract |
| format | Article |
| id | doaj-art-4ae127b85e22461d9626a57e194c0eaa |
| institution | Kabale University |
| issn | 1129-2377 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | The Journal of Headache and Pain |
| spelling | doaj-art-4ae127b85e22461d9626a57e194c0eaa2025-02-02T12:34:42ZengBMCThe Journal of Headache and Pain1129-23772025-01-0126112510.1186/s10194-025-01953-0Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathwayBaolong Li0Kaiming Yu1Xiongyao Zhou2Jialu Sun3Le Qi4Weiye Li5Tuo Yang6Weizhen Li7Ningning Wang8Xiaosong Gu9Shusen Cui10Rangjuan Cao11Department of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityDepartment of Hand and Foot Surgery, China-Japan Union Hospital of Jilin UniversityAbstract Neuropathic pain poses a significant clinical challenge, largely due to the incomplete understanding of its molecular mechanisms, particularly the role of mitochondrial dysfunction. Bioinformatics analysis revealed that pyroptosis and inflammatory responses induced by spared nerve injury (SNI) in the spinal dorsal horn play a critical role in the initiation and persistence of neuropathic pain. Among the factors involved, TSPO (translocator protein) emerged as a key regulator. Our experimental findings showed that TSPO expression was upregulated during neuropathic pain, accompanied by mitochondrial dysfunction, specifically manifested as impaired mitochondrial biogenesis, disrupted mitochondrial dynamics (including insufficient expression of mitochondrial biogenesis and fusion-related proteins, as well as significantly increased expression of fission-related proteins), and activation of pyroptosis. Pharmacological upregulation of TSPO, but not its downregulation, effectively alleviated SNI-induced pain hypersensitivity, improving mitochondrial function and reducing pyroptosis. Immunofluorescence staining confirmed that TSPO was primarily localized in astrocytes, and its expression mirrored the protective effects on mitochondrial health and pyroptosis prevention. PCR array analysis suggested a strong association between TSPO and the mitochondrial regulation pathway AMPK-PGC-1α. Notably, inhibition of AMPK-PGC-1α abolished TSPO effects on mitochondrial balance and pyroptosis suppression. Furthermore, Mendelian randomization analysis of GWAS data indicated that increased TSPO expression was linked to pain relief. Through drug screening, molecular docking, and behavioral assays, we identified zopiclone as a promising TSPO-targeting drug for pain treatment. In summary, this study enhances our understanding of the molecular interplay between TSPO, mitochondrial health, and neuropathic pain, highlighting TSPO as a potential therapeutic target for pain management. Graphical Abstracthttps://doi.org/10.1186/s10194-025-01953-0Neuropathic painTSPOAMPK-PGC-1αPyroptosisMitochondrial dynamicsOxidative stress |
| spellingShingle | Baolong Li Kaiming Yu Xiongyao Zhou Jialu Sun Le Qi Weiye Li Tuo Yang Weizhen Li Ningning Wang Xiaosong Gu Shusen Cui Rangjuan Cao Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway The Journal of Headache and Pain Neuropathic pain TSPO AMPK-PGC-1α Pyroptosis Mitochondrial dynamics Oxidative stress |
| title | Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway |
| title_full | Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway |
| title_fullStr | Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway |
| title_full_unstemmed | Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway |
| title_short | Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway |
| title_sort | increased tspo alleviates neuropathic pain by preventing pyroptosis via the ampk pgc 1α pathway |
| topic | Neuropathic pain TSPO AMPK-PGC-1α Pyroptosis Mitochondrial dynamics Oxidative stress |
| url | https://doi.org/10.1186/s10194-025-01953-0 |
| work_keys_str_mv | AT baolongli increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT kaimingyu increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT xiongyaozhou increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT jialusun increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT leqi increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT weiyeli increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT tuoyang increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT weizhenli increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT ningningwang increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT xiaosonggu increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT shusencui increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway AT rangjuancao increasedtspoalleviatesneuropathicpainbypreventingpyroptosisviatheampkpgc1apathway |